Form 4: Pulse Biosciences COO Buys Shares
Insider Transaction (Form 4)
Liane Rae Teplitsky, Chief Operating Officer of Pulse Biosciences, Inc., purchased 2,070 shares of common stock on August 26, 2026.
Summary
- Open-market purchase: acquired 1,036 Common Stock at $48.23 ($49,971) on August 26, 2026; holds 1,036 after (Direct).
- Open-market purchase: acquired 1,034 Common Stock at $48.35 ($49,994) on August 28, 2026; holds 2,070 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $99,965, committing personal capital to the stock.
Insider Transactions
Liane Rae Teplitsky — Officer (Chief Operating Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-26 | Open-market purchase | Common Stock | 1,036 | $48 | $50.0K | 1,036 |
| 2026-08-28 | Open-market purchase | Common Stock | 1,034 | $48 | $50.0K | 2,070 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-26 | Open-market purchase (1,036 shares) |
| 2026-08-28 | Open-market purchase (1,034 shares) |
Keywords
insider transaction, Form 4, PLSE, PULSE BIOSCIENCES, INC., bullish, Liane Rae Teplitsky
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.